Dr. DeLeon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
80 Mahalani St
Wailuku, HI 96793Phone+1 808-243-6000
Education & Training
University of HawaiiResidency, Internal Medicine, 2011 - 2014- University of Hawaii, John A. Burns School of MedicineClass of 2011
Mayo Clinic College of Medicine and Science (Phoenix)Fellowship, Hematology and Medical Oncology
Certifications & Licensure
HI State Medical License 2014 - 2026
AZ State Medical License 2015 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 21 citationsA pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.Daniel H. Ahn, Pedro Luiz Serrano Uson Junior, Peter Masci, Heidi E. Kosiorek, Thorvardur R. Halfdanarson
Investigational New Drugs. 2021-08-31 - 27 citationsNeutropenic diets to prevent cancer infections: updated systematic review and meta-analysisMohamad Bassam Sonbol, Tania Jain, Belal Firwana, Talal Hilal, Thomas DeLeon
BMJ Supportive & Palliative Care. 2019-04-04 - 27 citationsEmerging role of precision medicine in biliary tract cancersJames M Bogenberger, Thomas DeLeon, Mansi Arora, Daniel H. Ahn, Mitesh J. Borad
NPJ Precision Oncology. 2018-10-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
